This article will address the issue of Propallylonal, which has gained relevance in recent times due to its impact on society. Different aspects related to Propallylonal will be explored, from its origin to its influence in different areas, including its implications in people's daily lives. The different perspectives that exist around Propallylonal will be analyzed, as well as the possible challenges and opportunities it represents. This article seeks to deepen the knowledge about Propallylonal and generate reflection on its importance in the current context.
![]() | |
Clinical data | |
---|---|
Other names | 5-isopropyl-5-(β-bromoallyl)barbituric acid |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.008.088 |
Chemical and physical data | |
Formula | C10H13BrN2O3 |
Molar mass | 289.129 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Propallylonal (trade names Nostal, Quietal, Ibomal) is a barbiturate derivative invented in the 1920s.[1] It has sedative, hypnotic and anticonvulsant properties,[2] and is still rarely prescribed as a sleeping medication in some Eastern-European countries.